Congenital Bullous Syphilis: A Case Report from Italy and a Comprehensive Literature Review

Edoardo Cammarata1, Elia Esposto1, Nunzia Di Cristo1

  • 1SCDU Dermatologia, Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.

PubMed

Insights

Congenital bullous syphilis, a rare sign of congenital syphilis, presents with distinct skin lesions and aids early detection. Prompt diagnosis and penicillin treatment are vital for preventing severe outcomes and mortality in newborns.

Area of Science:

  • Neonatology
  • Dermatology
  • Infectious Diseases

Background:

  • Congenital syphilis poses a significant global health risk, potentially causing severe infant morbidity and mortality.
  • Early detection of congenital syphilis is critical, and subtle signs like bullous lesions (congenital bullous syphilis or pemphigus syphiliticus) can be key indicators.

Purpose of the Study:

  • To systematically review existing literature on congenital bullous syphilis.
  • To analyze clinical patterns, diagnostic methods, treatment, and outcomes of this rare manifestation.

Main Methods:

  • Systematic review of Medline (PubMed), Embase, and Cochrane Central Register of Controlled Trials.
  • Inclusion of a newly documented case for comprehensive analysis.
  • Extraction of demographic, clinical, laboratory, radiological, treatment, and outcome data.

Main Results:

  • Twenty-four cases of congenital syphilis with bullous lesions were identified; twenty were analyzed.
  • Three distinct clinical patterns of bullous lesions were observed: palmoplantar, acral, and diffuse bullous-erosive.
  • Intravenous penicillin G was the primary treatment, with most infants achieving remission, though severe respiratory involvement correlated with mortality.

Conclusions:

  • Bullous syphilis serves as a crucial early indicator of congenital syphilis, necessitating prompt recognition and diagnosis.
  • Effective management relies on maternal screening, neonatal testing, clinical examination, and timely penicillin therapy.
  • Heightened clinical vigilance and adherence to screening guidelines are essential for improving neonatal outcomes and preventing severe complications or death.